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A full-length complementary DNA (cDNA) clone encoding the guinea pig brain A 2 adenosine 
receptor has been isolated by polymerase chain reaction (PCR) and low-stringency-hybridization 
screening of a guinea pig brain cDNA library. This eDNA contains a long open reading frame 
encoding a 409-amino acid-residue protein which is highly homologous to the A2 adenosine re- 
ceptors previously cloned from other species. Hydrophobicity analysis of the deduced protein 
sequence reveals seven hydrophobic regions, characteristic of a member of the G-protein-coupled 
receptor superfamily. Radioligand binding assay and functional (GTPase and cAMP) assays of the 
receptor, transiently expressed in mammalian cells, demonstrate typical characteristics of the A2 
type adenosine receptor. The messenger RNA (mRNA) of this Aa receptor is found in the brain, 
heart, kidney and spleen. Receptor autoradiography with [3H]CGS21680, a specific A2 agonist, 
and in situ hybridization with A 2 cRNA probe in guinea pig brain indicate that the receptor is 
expressed exclusively in the caudate nucleus. The pharmacological profile and anatomical distri- 
bution of this receptor indicate that it is of the A2. subtype. This work represents the first cloning 
of an A2~ receptor in a rodent species, offers a complete pharmacological characterization of the 
receptor and provides an anatomical comparison between binding profile and gene expression of 
the receptor. 
KEY WORDS: Gs-coupled receptor; adenylyl cyclase; radioligand binding; mammalian cell expression; in 
situ hybridization; caudate/putamen. 
I N T R O D U C T I O N  
Adenosine, a member  of the purinergic neurotrans- 
mitter system, mediates a variety of important physio- 
logical functions, such as sedation, pain modulation, pre- 
synaptic inhibition of neurotransmitter release, inhibition 
of cardiovascular activity, regulation of renal glomerular 
filtration, and regulation of immune system, white blood 
cell and platelet functions (24,40). Adenosine initiates 
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Abbreviations: ADAC, adenosine amine congener; BA, N%benzy- 
ladenosine; bp, nucleotide base pair; cAMP, cyclic adenosine 3',5'- 
monophosphate; CCPA, 2-chloro-N6-cyclopentyladenosine; CGS 21680, 
2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adeno- 
sine hydrochloride; CHA, N~-cyclohexyladenosine; CNS, central ner- 
vous system; CPA, N6-cyclopentyladenosine; CPX, 8-cyclopentyl-l,3- 
dipropyLxanthine; DME, Dulbecco's modified Eagle's medium; DMPX, 
3,7-dimethyl-l-propargytxanthine; DPMX, 1,3-dipropyl-7-meth- 
ylxanthine; DPX, 1,3-dipropyl-8-(2-amono-4-chlorophenyl)xanthinc; 
FCS, fetal calf serum; IBMX, 3-isobutyl-l-methyNanthine; KHB, Kreb- 
HEPES buffer; MECA, 5'-N-methylcarboxamidoadenosine; NECA, 
5'-N-ethylcarboxamidoadenosine; D-PBS, Dulbecco's phosphate buff- 
ered saline; PCR, polymerase chain reaction; R-PIA, R(-)-N6-(2 - 
phenylisopropyl)adenosine; SSPE, sodium chloride-sodium phos- 
phate-EDTA buffer; TM, transmembrane domain; XAC, xanthine amine 
congener. 
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these actions by binding to its specific receptors in the 
membranes of target cells. Adenosine receptors are phar- 
macologically classified into two main types, A1 and A2. 
The A1 type adenosine receptor inhibits adenylyl cyclase 
and therefore decreases cAMP levels, while A2 stimu- 
lates adenylyl cyclase (35). Species differences in high- 
affini ty A 1 and A 2 binding have been reported based on 
the binding studies with mammalian brain membranes 
(6,36). A1 (16,17,19,26,38) and A2 (16,18,25,34) aden- 
osine receptors have been cloned from several species. 
This has established a new subfamily within the super- 
family of the G-protein-coupled receptors; new adeno- 
sine receptor subtypes (42), which had not been discerned 
by binding studies, have emerged from molecular clon- 
ing including the A2, and A2b subtypes. However, the 
A2a subtype has only been cloned from dog and human, 
making it difficult to characterize its anatomy and phar- 
macology in smaller experimental animals. Here we re- 
port the cloning of a cDNA, named gpA2R, encoding 
the Aza adenosine receptor from guinea pig brain; we 
describe the pharmacological characterization of this re- 
ceptor in transiently transfected ceils, and its expression 
in guinea pig brain and other tissues. 
EXPERIMENTAL PROCEDURE 
Poly(A) RNA preparation and cDNA library construction. Total 
RNA was isolated from male Hartley guinea pig brains by guanidinium 
thiocyanate extraction followed by centrifugation in cesium chloride 
solution (28). Poly(A) + RNA was purified using an oligo-dT cellulose 
spun column (Pharmacia). The construction of cDNA library was prin- 
cipally based on the method developed by Okayama and Berg (23) 
and modified by Gubler and Hoffman (12). The first-strand cDNA was 
synthesized by AMV reverse transcriptase using oligo(dT)-Not I Primer- 
Adaptor [oligo(dT)15 containing Not I site on its 5' side, Promega]; 
the second strand cDNA was synthesized using E.coli DNA polymer- 
ase I and RNase H. After treatment with T4 DNA polymerase to blunt 
their ends, the double-stranded cDNAs were ligated with Bst XI linker 
(Invitrogen) by T4 ligase at 14~ for 24 h. The cDNAs were digested 
by restriction enzyme Not I to create Not I sticky ends, then loaded 
on 1% agarose gel and electrophoresed for size fractionation. The 
cDNAs with sizes > 1.5 kb were electroeluted from the gel to DE81 
ion exchange paper (Whatman) and recovered by eluting with 1 M 
NaCI. After ethanol precipitation and washing, the cDNAs were uni- 
direetionally inserted into the Bst XI-Not I sites of pME18S expression 
vector by T4 ligase to construct the cDNA library. This size-fraction- 
ated (>1.5 kb) guinea pig brain cDNA library was composed of 1.8 
x ~I0 ~ independent colonies transformed into host DHs~ competent 
ceils. 
The pME18S vector(20), containing the Hae II-Aat-II fragment 
from pUC18, the stuffer region from plasmid CDM8 and the SR,~ 
promoter (37), with stop codon in each frame immediately after the 
cDNA insert, is a high-copy numbered ( -5 -10  mg plasmid/L culture), 
small vector (3.4 kb) plasmid with a strong promoter, suitable for 
constructing size-selected, unidirectional cDNA libraries and for 
expression in different mammalian cell systems. 
Oligonueleotide Primer Design and PCR Amplification. Six oli- 
gonucleotides were synthesized based on published G-protein-coupled 
receptor eDNA sequences. 
Three forward: 
(1) 5 ' -AAC(T)C(T)A(T)ITTC(T)A(C)TIATIA(T) CIC- 
TIGCITC(G)IGCI GA-3'; 
(2) 5 ' -A(C)GITTIC(T)TIATGTGC(T)AAC(T)CTIA 
(T)C(GlC(T)rrc(T) 6CtGA-3'; 
(3) 5'-ACIOTITAC(T)ATIACtCAC(T)C(T)TIA(T)C(G) IA- 
TIGCIGA-3'. 
Three reversed: 
(4) 5 '-GCC(T)TTIGTA(G)AAIATIGCA(G)TAIAGA(G) 
AAIGGA(G)TT-3'; 




Every possible combination of one forward and one reversed oli- 
gonucleotides was employed as one set of primers for polymerase chain 
reaction (PER) (27). 
Taq polymerase and all other PCR reagents were purchased from 
Perkin Elmer. Guinea pig brain cDNAs were used as PCR templates. 
Five fmol of DNA templates, 1 ixM of each primer, 200 IxM of each 
dNTP and 5 units ofTaq Polymerase were used in each 100 ~l-volume 
reaction. The PCR temperature cycle on the DNA Tempcycler (Coy 
Laboratory) was set as follows: for the first five cycles, denaturation 
at 94~ for 1 rain, anneaIing at 37~ for 2 rain, extension at 50~ for 
5 min; for the next 30 cycles, denaturation at 94~ for I rain, annealing 
at 50~ for 2 min and extension at 72~ for 3 min; the last five cycles 
have an extension time of 10 rain at 72~ in each cycle. 
Aliquots of the PCR products were directly loaded on 1.2% aga- 
rose gel to analyze their sizes. DNAs from bands of 0.4-1.2 Kb were 
recovered by eleetroelution, ligated into Eco RV site of pBluescript 
KS II (Stratagene) for sequencing analysis and for preparing 32p-la- 
beled probes for the colony hybridization. 
Colony Hybridization and DNA Sequencing. About 3 x 105 E,coli 
colonies from the guinea pig brain cDNA library were lifted onto 
Nytran filters (S&S). PCR product probe was labeled with 3zp by the 
random primer method (5). The conditions for low stringency hybrid- 
ization were: 35% forrnamide, 5 x SSPE, 5 x Denhardt's solution, 
0.5% SDS, 100 vg/ml denatured salmon sperm DNA (Pharmacia), 1 
x 106 cpm probe/ml, 42~ 24 h. Washing was conducted at 37~ 
three times with 2 x SSPE, 0.2% SDS for 30 min each. Positive 
colonies were picked and further purified to single clones by second 
round screening and southern hybridization with 32p-probes. 
Both strands of cloned cDNA were sequenced by dideoxynucleo- 
tide chain termination method (30) with Sequenase (USB). DNA and 
deduced protein sequences were analyzed by GCG programs (Wis- 
concin). 
Mammalian Cell Transfection and Receptor Binding Assay. Sim- 
ian COS-7 cells were transfected with CsCl-gradient-centrifugation- 
purified plasmids by electroporation (22). Exponentially growing COS- 
7 cells were plated (5 x l0 s cells/10 cm dish) in DME medium with 
10% FCS and cultured in a 37~ 5% COz incubator. After 24h, cells 
were harvested and washed twice with D-PBS, then resuspended in 1 
ml D-PBS containing 10 >g of plasmid DNA in a sterile electropor- 
ation cuvctte. After sitting on ice for 5 min, the cells were electro- 
porated (330 pxF, 300 V, 4 ~ C) in a Cell-Porator (BRL), then sat on 
ice for 5 rain, followed by suspension in 10 ml DMEM containing 
10% FCS in a cell culture dish and incubated at 37~ 5% CO2 
After three days of culturing, transfected cells were harvested by 
treatment with D-PBS (without calcium and magnesium) containing 
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0.5 mM EDTA, 0.01% sodium azide, washed three times with KHB 
(115 mM NaCI, 4.8 mM KC1, 2.5 mM CaClz, 5 mM MgCI z 25 mM 
HEPES, pH adjusted to 7.4 with NaOH) and resuspended in 1 x 100 
cells/ml in KHB. Receptor binding assays were performed in 1 ml 
KHB with 1 x 105 cells, competitors and radiolabeled Iigands. In 
order to label different types of adenosine receptors, tritiated A1 ag- 
nnists 2-chloro-N~-[cyclopentyl-2,3,4,5-3H]-Cyclopentyladenosine 
([3H]CCPA, specific activity: 35.4 Ci/mmole, NEN) and Cyclohexy- 
ladenosine ([3H]CHA, 30.2 Ci/mmole, NEN), tritiated A1 antagonist 
8-[dipropyl-2,8-3H(N)]CyclopentyI-1,3-dipropylxant hine ([3H]CPX, 
108.0 Ci/mmole, NEN), and tritiated A2 agonist [carboxyethyl-~H(N)]- 
CGS 21680 (39.6 Ci/mmole, NEN) were used. Unlabeled tigands (all 
from Research Biochemicals Incorporated, MA) used for competition 
were: the A1 selective agonists CCPA, CPA and CHA, relatively A1 
selective agonists ADAC, R-HA and BA, the A~ selective antagonists 
CPX and DPX, the relatively A1 selective antagonists XAC and IBMX, 
the selective Aa agonist CGS 21680 HCI, the relatively A~ selective 
agonist MECA, the relatively selective Az antagonists DMPX and 
DPMX, and the non-selective agonist NECA, as well as adenosine 
and ATP. For saturation studies, various concentrations of radiolabeied 
ligands were used, nonspecific binding was determined in the presence 
of 20 ~M unlabeled R-PIA for A1 and 20 ~M unlabeled CGS 21680 
HC1 for A2; in a parallel experiment, 5 units/ml of adenosine deami- 
nase was included in the binding assay buffer to determine the influ- 
ence of endogenously released adenosine in this binding system. For 
competition studies, minimum amounts of radiolabeled iigands were 
used to give about 3000 cpm specific binding per tube, and various 
concentrations of unlabeled ligands were used as competitors. The 
assay reaction mixtures were incubated at room temperature for 1.5 h 
and stopped by sitting on ice for 5 rain. Cells bound with radioligands 
and free ligands were separated by filtering through glass fiber filters 
(#32, S & S) on a multi-channel cell harvester (M-24S, Brandel). The 
filter membranes were counted for radioactivity in scintillation solu- 
tion. Binding assay data were presented as the mean value of three 
experiments, and analyzed by the Ligand program (21). 
GTPase Assay. GTPase assays (2) were performed with tran- 
siently transfected COS-7 cells. Briefly, plasmid pME18S-gpA2R 
transfected COS cell membranes were prepared by homogenization 
and centrifugation in I0 mM Tris-HC1 buffer containing 0. t m M  EDTA, 
pH 7.5. Ten mg of membrane protein in a 10 ~1 volume was added 
to 85 ~1 reaction mixture containing 0.5 ~M ['y-32p]GTP, 1 mM 
AppNHp, 1 mM ATP, 1 mM Ouabain, 10 mM creatine phosphate, 5 
units of creatine phosphokinase, 2 mM dithiothteitol, 5 mM MgC12, 
100 mM NaC1, 0.1 mM EDTA, 12.5 mM Tris-HCl, pH 7.5, then 
placed on ice before the addition of adenosine receptor agonists. Im- 
mediately after the addition of A~ agonist CPA (final concentration: 
10 ixM and 1 ~M) or A2 agonist CGS 21680 (final concentration: 10 
~M and 1 tzM), the reaction tubes were transferred to 37"C for 20 
min. The reaction was terminated on ice with the addition of 0.9 ml 
of stop solution containing 20 mM phosphoric acid and 5% activated 
charcoal, pH 2.3. After centrifugation in an Eppendorf microcentrifuge 
at 4 ~ C for 10 min, the radioactivity was measured from the super- 
natants. 
Cyclic AMP Assay. COS-7 cells transfected with plasmid pME18S- 
gpA2R were cultured in DMEM, 10%FCS for two days, washed twice 
with IMDM, and then cultured in IMDM, 10% Hyclone FCS. Differ- 
ent concentration of the A~ agonist CPA, the Az agonist CGS 21680, 
or the A2 antagonist DMPX were added to the cell culture and incu- 
bated at 37 ~ C for 30 rain. To terminate the reaction, 30% trichloro- 
acetic acid (ice cold, equal volume to the cell culture media) was added 
~o the dish. The cells were scraped into a glass test tube and put on 
ice for 30 min for a complete precipitation. After centrifugation at 
2000 g at 40 C for 10 min, the supernatant was eiher extracted, ly- 
ophitized on a Speed Vac and resuspended in 50 mM Tris-HC1, 2 mM 
EDTA, pH 7.5. Cyclic AMP levels were measured with a cAMP Assay 
Kit (TRK 432, Amersham). 
Northern Blot Analysis. All the Northern and in situ hybridiza- 
tions were conducted with 3zp or 35S-labeled cRNA riboprobes. A2 
cRNA riboprobe was produced from a 900bp Pst I fragment of the 
gpA2R eDNA ligated into pBluescript KS I I ( -  ) (Stratagene). [32p]UTP 
or psS]UTP-labeled Riboprobes were produced using either T3 or T7 
transcription systems in a standard labeling reaction mixture. The re- 
action was incubated at 37~ for 90 minutes, labelled probe being 
separated from free nucleotides over a Sephadex G-50 column. 
Total RNA was extracted from brain and peripheral tissues of a 
male Hartley guinea pig using GITC and LiCl. The RNA samples 
were fractionated on a 1% agarose-formaldehyde gel, electrophoresed 
and then transferred onto a nylon filter (Nytran). The filter was hy- 
bridized with 5 X 10 s cpm/ml 32P-labeled RNA probe from gpA2R 
under high stringency conditions (50% Formamide, 5 X SSPE, 5 X 
Denhardt's reagent, 0.5% SDS, 70~ 24 h). The filter was washed 
once with 1 X SSPE, 0.5% SDS at 70~ for 30 min and twice with 
0.1 X SSPE, 0.5% SDS at 70~ for 30 rain. and then exposed to an 
x-ray film (Kodak) with two intensifying screens for 7 days at - 80~ 
In Situ Hybridization. Guinea pig brain sections were removed 
from storage at -80~ and placed directly into 4% buffered parafor- 
maldehyde at room temperature. After 60 minutes, slides were rinsed 
in isotonic phosphate buffered saline (I0 minutes) and treated with 
proteinase K (1 >g/ml in 100 mM Tris/HCL, pHS.0) for 10 minutes 
at 37~ Subsequently, sections underwent successive washes in water 
(1 minute), 0.1 M triethanolamine (pH 8.0, plus 0.25% acetic anhy- 
dride) for 10 minutes and 2X SSC (0.3 mM NaC1, 0.03 mM sodium 
citrate, pH 7.2) for 5 minutes. Sections were then dehydrated through 
graded alcohols and air dried. 
Post-fLxed sections were hybridized with 1.0 x 10 ~ dpm [35S]UTP- 
labeled riboprobes in hybridization buffer containing 75% formamide, 
10% dextran sulphate, 3X SSC, 50 mM sodium phosphate buffer 
(pH7.4), 1X Denhardts solution, 0.1 mg/ml yeast tRNA and 10 mM 
dithiothreitol in a total volume of 25 ml. The diluted probe was applied 
to sections on a glass coverslip which was sealed into place with rubber 
cement. Sections were hybridized overnight at 55~ in a humid en- 
vironment. Az probe specificity was confirmed by absence of signal 
in both sections labeled with sense Az probe and sections pre-treated 
with RNase prior to hybridization with antisense (cRNA) Az probe. 
Post-hybridization the rubber cement was removed and sections 
were washed in 2X SSC for 5 minutes and then treated with RNase A 
(200 l.zg/ml in 10raM Tris/HCL, pHS.0, containing 0.5M NaCI) for 
60 minutes at 37~ Subsequently, sections were washed in 2X SSC 
for 5 minutes, 1 x SSC for 5 minutes, 0.5 x SSC for 60 minutes at 
hybridization temperature, 0.5 • SSC at room temperature for 5 min- 
utes and then dehydrated in graded alcohols and air dried. For signal 
detection, sections were placed on Kodak XAR-5 X-ray film and ex- 
posed for 2 days at room temperature. 
In Vitro ReceptorAutoradiography. [3H]CGS 21860 binding was 
performed according to previously published autoradiographic methods 
(4). Slide-mounted tissue sections were preincubated in 0.17 M Tris/ 
HC1, pH 7.4, for 20 minutes at room temperature. Subsequently, sec- 
tions were incubated with I0 nM [3H]CGS 21860 (+0.5 i.u./ml aden- 
osine deaminase) for 90 minutes at room temperature. Post-incubation, 
slides were washed in incubation buffer (2 x 5 minutes) and dried in 
a stream of cold air. Non-specific binding was determined in the pres- 
ence of 10 ~M adenosine. Sections were apposed to tritium-sensitive 
Hyperfilm (Amersham) and exposed at room temperature for 14 days. 
616 Meng, Xie, Chalmers, Morgan, Watson, and Akil 
RESULTS 
Cloning of gpA2R cDNA. PCR using guinea pig 
brain cDNA as templates amplified severaI bands with 
sizes compatible with the G-protein-coupled receptor 
fragments flanked by the corresponding primers. Se- 
quence analysis of these PCR fragments revealed differ- 
ent sequences with various homologies (from 62%-88%) 
to cDNA sequences encoding dog and rat A1 and A2 
adenosine receptors. The mixture of these PCR products 
was directly labeled with ~2p and used as probe to screen 
guinea pig brain pME18S cDNA library by low-strin- 
gency hybridization to get full-length clones. Twenty- 
one positive clones were obtained in 3 x 105 colonies 
screened. One of these full-length clones, gpAzR, showed 
highest homology to A2 adenosine receptors. 
Sequence Analysis of gpA2R. Clone gpA2R con- 
tained an insert of 2,085 base pairs (bp) followed by a 
poly(A) tail. A long open reading frame was found after 
an ATG (Methionine) at position 16-18. The sequences 
around this ATG met the Kozak consensus sequence 
criteria for a translation initiation site (14). This open 
reading frame encodes a protein with 409 amino acids 
(including the first methionine) (Fig. 1) and a calculated 
molecular mass of 44,831 Daltons. 
Genebank search showed that the deduced amino 
acid sequence of gpA2R is highly homologous to the 
previously cloned A2 adenosine receptors from other 
species: 88% identity with dog A2a receptor, 87% with 
human A2a, 61% identity with rat A2b , and 58% with 
human A2b. The protein sequence of gpA2R also shares 
51% identity with dog, rat and bovine A1 adenosine re- 
ceptors. Its similarities with other members of the G- 
protein coupled receptor superfamily are lower but sig- 
nificant (for example, in transmembrane regions, 34% 
identity with rat 5-HT~a receptor, 30% with human and 
rat cq-adrenergic receptor, 29% with human histamine 
H 2 receptor, and 29% with human D2 dopamine recep- 
tor). 
Computer-aided hydrophobicity analysis (method 
of Kyte & Doolittle) (15) of gpA2R revealed that it con- 
tains seven hydrophobic segments, each consisting of 
about 23-27 amino acid residues, long enough to form 
a c~-helix to span the cell membrane. These hydrophobic 
regions possess the highest similarities to many other G- 
protein-coupled receptors. Several features of the amino- 
acid sequence of gpAzR are noteworthy, and are also 
conserved in all other cloned A2 receptors: The N-ter- 
minal hydrophilic region before the TM I is very short 
(4 residues), and there is no potential N-glycosylation 
site on this N-terminal extracellular end; two potential 
N-glycosylation sites can be found in the second extra- 
cellular loop; there are 18 serine and threonine residues 
after TM VII, which may participate in the mechanism 
of receptor phosphorylation. The deduced protein se- 
quence of gpA2R does not have a signal sequence on its 
N-terminus. 
Receptor Binding Assay on Transfected COS- 7 Cells. 
Simian COS-7 cells, which endogenously expressed nei- 
ther gpA1R or gpA2R positively-hybridizing mRNAs nor 
detectable [3H] CPX or [3H]CGS 21680 binding sites, 
were transfected with plasmid gpAzR. Binding assays 
(both saturation and competition studies) were per- 
formed on whole cells. 
Cells transfected with plasmid gpA2R expressed 
saturable, high affinity binding sites for selective A2 ag- 
onist [3H]CGS 21680 (K~ = 5.7 nM), specific binding 
was about 75-80% of total binding (Fig. 2A). Al-selec- 
tive agonists [3H]CCPA, [3H]CHA and antagonist 
[3H]CPX showed very little binding to gpA2R (data not 
shown). Binding assays performed with cell membrane 
preparations gave similar results. 
In competition studies, the selective A2 agonist 
CGS21680 competed well with [3H]CGS21680 binding 
on gpA2R transfected COS-7 cells, the non-selective 
adenosine agonist NECA and antagonist XAC were also 
good competitors, while the relatively selective A 2 ag- 
onist MECA and the A2 antagonists DMPX and DPMX 
exhibited moderate competitions. In contrast, the selec- 
tive A 1 agonists CCPA, CHA and the A1 antagonist CPX 
competed very poorly. ATP did not compete 
[3H]CGS21680 binding. The rank order of these ligands 
to compete with [3H]CGS21680 binding on gpA2R trans- 
fected cells was as follows: CGS21680 > > XAC = 
NECA > > adenosine = MECA = DMPX = DPMX 
> R-PIA = CPA > CHA > CPX > > ATP (Fig. 2B). 
The Effects of A2 Ligands on GrPase Activity and 
cAMP Level in gpA2R Transfected COS Cells. The A2 
agonist CGS 21680 stimulated GTPase activity up to 
37% above control level and increased cAMP level by 
two-fold in gpAzR transfected cells. These effects could 
be partially blocked by the A2 antagonist DMPX. A 1 
agonists had very little effect on GTPase activity and 
cAMP levels in the same transfectants (Table I). 
Northern Hybridization in Different Guinea Pig 
Tissues. Northern blot analysis of total RNAs from 8 
tissues of the guinea pig probed with gpA2R RNA probe 
showed a single hybridized transcript of approximately 
3 kb in brain, heart, spleen and kidney (Fig. 3). 
In Situ Hybridization. Within the brain, gpA2R 
mRNA appeared to be exclusively localized in the cau- 
date/putamen (Fig. 4). After a two-week exposure time, 
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1 gcggccgcc cctgcc ~t gagct cc~cggtgt acat cacagt ggagct ggt cat t gc cgt g 
M S S S V Y I T V E L V I A V 15 
............................... 
61 ctqqccattctgggcaacgtgctqgtgtgctgggccqtgtggatcaacagcaa~ctgcag 
L A I L G N V L V C W A V W I N S N L Q 35 
.... TM-I ................................... 
121 a acgt caccaact act t cgt ggt gt cgct ggcggcggccgacat cgcagtgggt gt get c 
N V T N Y F V V S L A A A ~ I A V G V L 55 
.................................. TM-2 ........ 
181 gccat CCCCtt cgc~atcaccat cagt accggctt ct gt gccgcc~gccatggct gCCtC 
A I P F A I T I $ T G F C A A C H G C L 75 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
241 ttcttcgcctgcttcgtcctggtcctcacacagagttccatcttcagcctcctqqccatc 
F F A C F V L V L T Q S S I F S L L A ~ 95 
.............................. TM-3 ........................ 
301 gccattgaccgctacatcqccatccqgatccccctgcggtacBatggcttgqtgacctgc 
A I D R Y I A l R I P L R Y N G L V T C 115 
361 acgagggccaagggc~tcattgcaatct~c~qqgtgctgtcatttg~catcggcctqacg 
T R A K G I I A I C W V L S E A I G L T 135 
................................ TM-4 .......... 
421 cccatgctaggctggaacaactgcaqtc~gccaaaggqggacaagaaccactcagagagc 
P M L G W N N C S Q P K G D K N H 5 E ~ 155 
481 t gcgacgagggccaggt gacctgt ct ct t cgaagat gt ggtgcccatgaact acat ggt a 
C D E G Q v T C L F E D V V p M N Y M V 175 
...................... 
541 t actacaacttctt cgcttttgtgctggzgcccttqctgctcatgctgggcat ctacctg 
Y Y N F F A F V L V P L L L M L G I Y L 195 
............... TM-5 ........................... - ........... 
601 aggat ctt cot ggcagcccggcgacagctgaaacaaatggaaagccagc ct ctgccgggg 
R I F L A A R R Q L K Q M E S Q P L P G 215 
661 gaacggactcggtccacactgcagaagqaggtccatgccgccaagtcactg~ccatcatt 
E R T R S T L Q K E V H A A K S L A I I 235 
721 gt.ggggct Ct t cgcact ct gctggct gcccctgc at at cat caact ~ct t cacct tct t c 
V G L F A L C W L P L a I I N C F T F F 255 
...................... TM- 6 ................................ 
781 t gc~ccgagtgtggccatgccccacct t gqct cadge coat gaccatcat cctct cccat 
C P E C G a A ~ P W L M S M T I I L S H 275 
........................ TM-7--- 
841 ggcaattccgtggt caaccccctcat ctatgcc~atcgcatccgt gagttccgccagacc 
G ' N S V V N P L I Y A Y ~ I K E F R Q T 295 
.................................. 
901 t t c ~gcaagat cat ccgcagccacat cct gaggagaagggaact ct t caaqgcaggaggc 
F R K ~ I R S H I L R K R E L F K A G G 315 
961 accagtgccaqgg~ctc~gcggctcacagccctgagggagagcsggtcagc~tccggctc 
T S A R A S A A H S P E G E Q V S L R L 335 
1021 aatggccaccccccaggggt at gggcca acggcagcgct ccccgt cct gagcagcggccc 
N G H P P G V W A N G S A P R ~ E Q R P 355 
1081 aat ggzt ~ tgt cctggggct ggtgagtggaaggagcgcccaaaggt cccacggagatgcc 
N G Y V L 'G L V S G R 'S A Q R S H G D A 375 
1141 agcct ct cagacgt ggagct CCt cagccat gagcacaagggaacat~t ccagag~ccccc 
S L S D V E L L S HI E H K G T C P E S P 395 
1201 agtctggaggaccccccggcccacggtqgagcaggagtgtcctgatggcccacagagttt 















Fig. L Nuc|eotide and deduced amino acid sequence of gpAzR. 
Nucleotides are numbered on the Idt of the rows and amino acids on the right. Possible N-gl>cosyhdon sites (*) are marked and polyadenybdon 
signal sequence underlined. Putative hydrophobic transmembrane domains TM-1 through TM-7 are underlined with broken lines. The sequence 
has been deposited to GenBank data base (accession no. U04201). 
the level of gpA2R mRNA expression in the caudate was 
8-fold greater (as measured by mean O.D.) than that in 
adjacent cortical areas. The complementary distribution 
of A2 receptor binding sites in this region indicates that 
A 2 receptors are intrinsically localized within the stria- 
turn. Az mRNA was undetectable within the cerebral 
cortex, hippocampus, substantia nigra and cerebellum 
(Fig. 4). 
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Fig. 2. Radio-ligand receptor binding assay on gpA2R transfected 
COS-7 cells. (A) Saturation curve of [3H] CGS21680 specific binding. 
Twenty micromoler of unlabeled CGS21680 are used as total dispace- 
ment. (B) Competition of [3H]CGS21680 specific binding by CGS21680 
(O), XAC (A), NECA ( ') ,  MECA (+),  adenosine (A), IBMX (t~), 
R-PIA (0) ,  DMPX (*), DPMX (a), CHA (~), CPA (X), CCPA (m), 
CPX (~), ATP ( ') .  
DISCUSSION 
As adenosine receptors, which positively activate 
adenylyl cyclase through Gs-protein, have been pro- 
posed to have As~ and Ash subtypes (1). A2a receptors 
have high-affinity binding for the specific As agonist 
CGS21680 and the endogenous ligand adenosine, while 
A2b bind CGS21680 and adenosine with considerably 
lower affinity (25,36). The anatomical distributions of 
the two subtypes of A2 receptors in the CNS are also 
very different: A2a receptors are located within the stria- 
tum, while A2b receptors are not found in the brain proper 
but only found in the hypophyseal pars tuberalis of the 
pituitary (34). 
The cloned guinea pig brain cDNA, gpAsR, ex- 
hibits highest homologies to the dog (88%) and human 
(87%) Asa adenosine receptors; its degrees of homology 
are lower to the Asb and A1 adenosine receptors (ap- 
proximately 60% to A2b and 50% to A1). The expressed 
gpAsR has high affinity binding (5.7 nM) for the A2 
selective agonist CGS21680. Stimulation of cells ex- 
pressing gpA2R by CGS21680 increases the cellular cAMP 
level. The gpAsR mRNA is located in the striatum of 
the brain. Therefore, this cloned gpAaR is likely to en- 
code an As, subtype adenosine receptor. As of this writ- 
ing, only the A2a receptors from dog and human have 
been cloned. Thus the guinea pig A2a receptor represents 
the first A2, subtype to be cloned from a rodent species. 
All the existing adenosine agonists and antagonists 
were developed, tested and defined with mammalian brain 
membrane preparations or whole animals prior to the 
molecular cloning of the adenosine receptors. Ob- 
viously, these systems contain a mixture of adenosine 
receptors  (A1, A s and other subtypes). The expression 
of a pure population of a single receptor subtype from 
cloned cDNA has proved to be an invaluable system for 
evaluating pharmacological ligands. With transiently ex- 
pressed guinea pig A t (data not shown) and Asa adeno- 
sine receptor, we have tested a dozen adenosine ligands 
and obtained their ligand selectivity profiles (LSP) and 
their receptor binding site signatures (BSS) (10). Clearly, 
CGS21680 displayed highly selective, high-affinity 
binding to gpA2R. NECA and MECA bound gpAs R with 
moderate affinities and poor selectivities. Antagonists 
DMPX and DPMX showed some selectivity towards Ae 
Control 
Table I. GTPase and cAMP Assay on gpA2R Transfected COS-7 Cells 
i 
CGS21680 (~M) CGS21680 (10 ~xM) 
10 1 0.1 + DPMX (10 ~M) CPA (10 ~M) 
GTPase actMty 100_+5 137_+6" 128• 109_+5 113• 107• 
(%) 
Cyclic AMP level 100 _+ 6 194 4- 7"* 172 -+ 4"* 138 -+ 3" 144 • 5* 128 _+ 3" 
(~) 
,,11 
Data are presented as Mean 4- SE of triplicates. In control group, GTPase activity and cAMP level of transfected COS-7 cells were measured 
without the application of ligands. *P<0.05, **P<0.01 as compared with control (Student t test). 
Guinea Pig A2 Adenosine Receptor 619 
1 2 3 4 5 6 7 8 
3.0 kb 
Fig. 3. Northern hybridization of RNAs from different guinea pig 
tissues. Guinea pig total RNAs from (1) brain, (2) heart, (3) lung, (4) 
spleen, (5) kidney, (6) liver, (7) stomach, and (8) intestine were probed 
with gpA2R riboprobe (9.0 • 106 cpm/20 ml) and exposed for 6 days 
at -80  ~ with two intensifying screens. The molecular weight was 
based on a RNA ladder (BRL) and a Ribosomal RNA marker (Phar- 
macia). 
but their affinities were also moderate. The endogenous 
Iigand adenosine bound gpA2R as well as A1 adenosine 
receptor with an affinity of about 20 nM. 
In situ hybridization studies demonstrated that the 
A2a receptor mRNA is exclusively expressed in the cau- 
date. The complementary distribution of adenosine Aza 
receptor binding in this region indicates that locally syn- 
thesised A2a receptors are present on striatal neurons. 
Most striatal neurons utilize GABA as a neurotransmitter 
and can be divided into two sub-populations on the basis 
of their efferent projections; striatopallidal neurons and 
striatonigral neurons (9). Striatopallidal neurons have been 
shown to express enkephalin while striatonigral cells 
coexpress dynorphin and substance P (9,11). A2a recep- 
tor mRNA has been shown to be co-localized with en- 
kephalin in striatal cells but not with substance P (31). 
Thus, striatal A2, receptors are likely to be more impor- 
tant in relation to striatopallidal circuitry as opposed to 
striatonigral. Such differentiation has important impli- 
cations for the functionality of striatal Aa, receptors and 
their involvement in the control of locomotor activity. 
Indeed, stimuIation of these sites may underlie the Io- 
comotor depressing effects of adenosine analogs (7). In 
addition, the A2~ receptor appears to be co-localized spe- 
Fig. 4. Comparative autoradiographfc localization of A2 receptor sites 
(left hemisphere) and gpAzR mRNA (right hemisphere) in horizontal 
sections of guinea pig brain. CPu, caudate/putamen. 
cifically with dopamine D 2 receptors in the caudate 
(32,33). Further understanding of the interactions be- 
tween dopaminergic nigrostriatal inputs and the actions 
of striatal adenosine are likely to be crucial to our un- 
derstanding of basal ganglia physiology and pathology. 
In addition to its role as a neurotransmitter in the 
CNS, adenosine acts in an autocrine or paracrine fashion 
to regulate mammalian cardiovascular, renal, and im- 
mune systems (40). The activation of adenosine recep- 
tors in the heart increases coronary blood flow via 
vasodilation of coronary arteries, decreases heart rate 
and contractility. The increase in coronary blood flow is 
thought to be mediated by A2 adenosine receptors (39). 
In the kidney, adenosine can decrease glomerular filtra- 
tion rate, stimulate renin release, and increase sodium 
excretion. The latter function is thought to be mediated 
by A2 adenosine receptors (8,13). Evidence also indi- 
cates that adenosine is involved in the immune system. 
While adenosine inhibits the production and stimulation 
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of lymphocytes (29), the activation of As receptors pro- 
tects endothelial cells from injury by inhibiting neutro- 
phil adherence (3). 
By Northern blot analysis, we have determined that 
gpA2R mRNA is found in the brain, kidney, and spleen. 
Given the reported functions of adenosine, the peripheral 
distribution of gpAzR mRNA is consistent with the idea 
that A2 type adenosine receptors may mediate some of 
the effects of adenosine in the cardiovascular, renal, and 
immune systems, as well as the CNS. 
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